|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Mol Endocrinol
16:987-997
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular recognition of agonist ligands by RXRs.
|
|
P.F.Egea,
A.Mitschler,
D.Moras.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The nuclear receptor RXR is an obligate partner in many signal transduction
pathways. We report the high-resolution structures of two complexes of the human
RXRalpha ligand-binding domain specifically bound to two different and
chemically unrelated agonist compounds: docosa hexaenoic acid, a natural
derivative of eicosanoic acid, present in mammalian cells and recently
identified as a potential endogenous RXR ligand in the mouse brain, and the
synthetic ligand BMS 649. In both structures the RXR-ligand-binding domain forms
homodimers and exhibits the active conformation previously observed with
9-cis-RA. Analysis of the differences in ligand-protein contacts (predominantly
van der Waals forces) and binding cavity geometries and volumes for the several
agonist-bound RXR structures clarifies the structural features important for
ligand recognition. The L-shaped ligand-binding pocket adapts to the diverse
ligands, especially at the level of residue N306, which might thus constitute a
new target for drug-design. Despite its highest affinity 9-cis-RA displays the
lowest number of ligand-protein contacts. These structural results support the
idea that docosa hexaenoic acid and related fatty acids could be natural
agonists of RXRs and question the real nature of the endogenous ligand(s) in
mammalian cells.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Jin,
and
Y.Li
(2010).
Structural and functional insights into nuclear receptor signaling.
|
| |
Adv Drug Deliv Rev,
62,
1218-1226.
|
 |
|
|
|
|
 |
Y.Sato,
N.Ramalanjaona,
T.Huet,
N.Potier,
J.Osz,
P.Antony,
C.Peluso-Iltis,
P.Poussin-Courmontagne,
E.Ennifar,
Y.Mély,
A.Dejaegere,
D.Moras,
and
N.Rochel
(2010).
The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.
|
| |
PLoS One,
5,
e15119.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Borel,
A.de Groot,
C.Juillan-Binard,
E.de Rosny,
V.Laudet,
E.Pebay-Peyroula,
J.C.Fontecilla-Camps,
and
J.L.Ferrer
(2009).
Crystal structure of the ligand-binding domain of the retinoid X receptor from the ascidian polyandrocarpa misakiensis.
|
| |
Proteins,
74,
538-542.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Fan,
J.J.Irwin,
B.M.Webb,
G.Klebe,
B.K.Shoichet,
and
A.Sali
(2009).
Molecular docking screens using comparative models of proteins.
|
| |
J Chem Inf Model,
49,
2512-2527.
|
 |
|
|
|
|
 |
M.I.Dawson,
M.Ye,
X.Cao,
L.Farhana,
Q.Y.Hu,
Y.Zhao,
L.P.Xu,
A.Kiselyuk,
R.G.Correa,
L.Yang,
T.Hou,
J.C.Reed,
P.Itkin-Ansari,
F.Levine,
M.F.Sanner,
J.A.Fontana,
and
X.K.Zhang
(2009).
Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
|
| |
ChemMedChem,
4,
1106-1119.
|
 |
|
|
|
|
 |
W.P.Lippert,
C.Burschka,
K.Götz,
M.Kaupp,
D.Ivanova,
C.Gaudon,
Y.Sato,
P.Antony,
N.Rochel,
D.Moras,
H.Gronemeyer,
and
R.Tacke
(2009).
Silicon analogues of the RXR-selective retinoid agonist SR11237 (BMS649): chemistry and biology.
|
| |
ChemMedChem,
4,
1143-1152.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Nakagawa,
and
V.C.Henrich
(2009).
Arthropod nuclear receptors and their role in molting.
|
| |
FEBS J,
276,
6128-6157.
|
 |
|
|
|
|
 |
J.Lu,
M.Chen,
G.T.Dekoster,
D.P.Cistola,
and
E.Li
(2008).
The RXRalpha C-terminus T462 is a NMR sensor for coactivator peptide binding.
|
| |
Biochem Biophys Res Commun,
366,
932-937.
|
 |
|
|
|
|
 |
K.Takamatsu,
A.Takano,
N.Yakushiji,
K.Morishita,
N.Matsuura,
M.Makishima,
H.I.Ali,
E.Akaho,
A.Tai,
K.Sasaki,
and
H.Kakuta
(2008).
Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety.
|
| |
ChemMedChem,
3,
454-460.
|
 |
|
|
|
|
 |
K.Takamatsu,
A.Takano,
N.Yakushiji,
K.Morohashi,
K.Morishita,
N.Matsuura,
M.Makishima,
A.Tai,
K.Sasaki,
and
H.Kakuta
(2008).
The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha/beta-dual agonist).
|
| |
ChemMedChem,
3,
780-787.
|
 |
|
|
|
|
 |
L.M.Sanderson,
P.J.de Groot,
G.J.Hooiveld,
A.Koppen,
E.Kalkhoven,
M.Müller,
and
S.Kersten
(2008).
Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics.
|
| |
PLoS ONE,
3,
e1681.
|
 |
|
|
|
|
 |
N.Kumaresan,
K.R.Sanjay,
K.S.Venkatesh,
R.K.Kadeppagari,
G.Vijayalakshmi,
and
S.Umesh-Kumar
(2008).
Partially saturated canthaxanthin purified from Aspergillus carbonarius induces apoptosis in prostrate cancer cell line.
|
| |
Appl Microbiol Biotechnol,
80,
467-473.
|
 |
|
|
|
|
 |
S.Vibet,
C.Goupille,
P.Bougnoux,
J.P.Steghens,
J.Goré,
and
K.Mahéo
(2008).
Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response.
|
| |
Free Radic Biol Med,
44,
1483-1491.
|
 |
|
|
|
|
 |
V.Nahoum,
A.Lipski,
F.Quillard,
J.F.Guichou,
Y.Boublik,
E.Pérez,
P.Germain,
A.R.de Lera,
and
W.Bourguet
(2008).
Nuclear receptor ligand-binding domains: reduction of helix H12 dynamics to favour crystallization.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
64,
614-616.
|
 |
|
|
|
|
 |
A.R.de Lera,
W.Bourguet,
L.Altucci,
and
H.Gronemeyer
(2007).
Design of selective nuclear receptor modulators: RAR and RXR as a case study.
|
| |
Nat Rev Drug Discov,
6,
811-820.
|
 |
|
|
|
|
 |
V.Nahoum,
E.Pérez,
P.Germain,
F.Rodríguez-Barrios,
F.Manzo,
S.Kammerer,
G.Lemaire,
O.Hirsch,
C.A.Royer,
H.Gronemeyer,
A.R.de Lera,
and
W.Bourguet
(2007).
Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
|
| |
Proc Natl Acad Sci U S A,
104,
17323-17328.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.E.Liu,
W.Pu,
J.Wang,
J.X.Kang,
and
Y.E.Shi
(2007).
Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids.
|
| |
FEBS J,
274,
3351-3362.
|
 |
|
|
|
|
 |
A.Bordoni,
M.Di Nunzio,
F.Danesi,
and
P.L.Biagi
(2006).
Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors.
|
| |
Genes Nutr,
1,
95.
|
 |
|
|
|
|
 |
J.Lengqvist,
A.Mata de Urquiza,
T.Perlmann,
J.Sjövall,
and
W.J.Griffiths
(2005).
Specificity of receptor-ligand interactions and their effect on dimerisation as observed by electrospray mass spectrometry: bile acids form stable adducts to the RXRalpha.
|
| |
J Mass Spectrom,
40,
1448-1461.
|
 |
|
|
|
|
 |
J.Lengqvist,
G.Alvélius,
H.Jörnvall,
J.Sjövall,
T.Perlmann,
and
W.J.Griffiths
(2005).
Electrospray mass spectrometry for the direct accurate mass measurement of ligands in complex with the retinoid X receptor alpha ligand binding domain.
|
| |
J Am Soc Mass Spectrom,
16,
1631-1640.
|
 |
|
|
|
|
 |
A.IJpenberg,
N.S.Tan,
L.Gelman,
S.Kersten,
J.Seydoux,
J.Xu,
D.Metzger,
L.Canaple,
P.Chambon,
W.Wahli,
and
B.Desvergne
(2004).
In vivo activation of PPAR target genes by RXR homodimers.
|
| |
EMBO J,
23,
2083-2091.
|
 |
|
|
|
|
 |
A.Luria,
and
J.D.Furlow
(2004).
Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos.
|
| |
Proc Natl Acad Sci U S A,
101,
8987-8992.
|
 |
|
|
|
|
 |
A.R.Barchuk,
R.Maleszka,
and
Z.L.Simões
(2004).
Apis mellifera ultraspiracle: cDNA sequence and rapid up-regulation by juvenile hormone.
|
| |
Insect Mol Biol,
13,
459-467.
|
 |
|
|
|
|
 |
C.L.Varley,
J.Stahlschmidt,
B.Smith,
M.Stower,
and
J.Southgate
(2004).
Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.
|
| |
Am J Pathol,
164,
1789-1798.
|
 |
|
|
|
|
 |
L.J.Schwimmer,
P.Rohatgi,
B.Azizi,
K.L.Seley,
and
D.F.Doyle
(2004).
Creation and discovery of ligand-receptor pairs for transcriptional control with small molecules.
|
| |
Proc Natl Acad Sci U S A,
101,
14707-14712.
|
 |
|
|
|
|
 |
Y.Brelivet,
S.Kammerer,
N.Rochel,
O.Poch,
and
D.Moras
(2004).
Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level.
|
| |
EMBO Rep,
5,
423-429.
|
 |
|
|
|
|
 |
S.Sanglier,
E.Leize,
A.Van Dorsselaer,
and
F.Zal
(2003).
Comparative ESI-MS study of approximately 2.2 MDa native hemocyanins from deep-sea and shore crabs: from protein oligomeric state to biotope.
|
| |
J Am Soc Mass Spectrom,
14,
419-429.
|
 |
|
|
|
|
 |
S.Svensson,
T.Ostberg,
M.Jacobsson,
C.Norström,
K.Stefansson,
D.Hallén,
I.C.Johansson,
K.Zachrisson,
D.Ogg,
and
L.Jendeberg
(2003).
Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation.
|
| |
EMBO J,
22,
4625-4633.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |